RBC Capital Maintains Outperform on Allscripts Healthcare, Raises Price Target to $19
RBC Capital analyst Sean Dodge maintains Allscripts Healthcare (NASDAQ:MDRX) with a Outperform and raises the price target from $17 to $19.
SVB Leerink Maintains Market Perform on Allscripts Healthcare, Raises Price Target to $19
SVB Leerink analyst Stephanie Davis maintains Allscripts Healthcare (NASDAQ:MDRX) with a Market Perform and raises the price target from $17 to $19.
Allscripts Healthcare Q2 EPS $0.15 Misses $0.17 Estimate, Sales $373.70M Beat $373.45M Estimate
Allscripts Healthcare (NASDAQ:MDRX) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.17 by 11.76 percent. This is a 16.67 percent decrease over earnings of $0.18 per share
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Stocks That Hit 52-Week Highs On Wednesday
This morning 122 companies reached new 52-week highs.
‘Fast Money Halftime Report’ Picks For June 11
On CNBC's "Fast Money Halftime Report," Shannon Saccocia said it might be a good time to enter Merck & Co., Inc. (NYSE: MRK).
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 216 companies hit new 52-week highs.
SVB Leerink Maintains Market Perform on Allscripts Healthcare, Raises Price Target to $16
SVB Leerink analyst Stephanie Davis maintains Allscripts Healthcare (NASDAQ:MDRX) with a Market Perform and raises the price target from $15 to $16.